Research Analysts Set Expectations for CLSD Q1 Earnings
Clearside Biomedical, Inc. (NASDAQ:CLSD – Free Report) – HC Wainwright upped their Q1 2025 earnings estimates for Clearside Biomedical in a note issued to investors on Monday, March 31st. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings of ($0.12) per share for the quarter, up from their prior forecast of […]
